Clinical trial Recruiting at 1 site Phase 4 Interventional Ages 18 to 41 Women only

Effects of Corpus Luteum on Frozen Embryo Transfer Pregnancies

Official title: Impact of the Presence of the Corpus Luteum on Pregnancies Obtained Through Frozen Embryo Transfer(FET): a Prospective Randomized Controlled Study

Run by Fundacion Clinic per a la Recerca Biomédica · NCT06896617 · Data updated 2026-11-12

This study is testing how the corpus luteum affects pregnancies from frozen embryo transfers to see if it influences things like heart health and fetal growth.

More Embryo Transfer trials

Quick facts

PhasePhase 4
Study typeInterventional
Ages18 Years to 41 Years
SexWomen only
Enrollment334 (estimated)
SponsorFundacion Clinic per a la Recerca Biomédica
Academic / other
Locations1 site (Barcelona, Spain)
StatusRecruiting
StartedFebruary 1, 2025
Main results expectedNovember 20, 2026
Study endsDecember 20, 2026
Registry record updatedApril 2, 2025
Trial IDNCT06896617 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are females aged 18-37 with regular menstrual cycles and available cryopreserved blastocysts for single embryo transfer.

Probably not a fit

Patients with recurrent pregnancy loss, recurrent implantation failure, or certain medical conditions such as polycystic ovarian syndrome or autoimmune diseases may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates the impact of the corpus luteum on pregnancies achieved through programmed frozen embryo transfer (PC-FET) and modified natural frozen embryo transfer (mNC-FET). It aims to assess differences in endothelial and placental function, maternal cardiovascular function, fetal growth, and fetal cardiovascular and cerebral programming. The study will also explore the relationship between these differences and the plasma concentrations of key secretion products from the corpus luteum that have vasoactive and angiogenic properties.

Why it matters

Potential benefit: If successful, this study could enhance the understanding of how the corpus luteum affects pregnancy outcomes, potentially leading to improved fertility treatments.

How similar studies have gone: While there is limited information on similar studies, the investigation of the corpus luteum's role in pregnancy outcomes is a relevant area of research that has shown promise in related contexts.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Female patients 18- 37 years old (both included) at the time of oocyte retrieval and less than 41 years of age at the time of embryo transfer.
* Regular menstrual cycles between 24 and 35 days.
* Availability of cryopreserved blastocysts from own gametes
* Indication for single embryo transfer.
* Patients who will be included in the LUTI study are candidates for either of the two procedures under study, and will have no contraindications for either procedure.

Exclusion Criteria:

* Recurrent pregnancy loss (3 or more).
* Recurrent implantation failure in previous IVF treatments (3 or more unsuccessful embryo transfers). .
* Diagnosis of polycystic ovarian syndrome, diabetes mellitus, chronic arterial hypertension, maternal heart disease and autoimmune diseases (Systemic Lupus Erythematosus (SLE) or Antiphospholipid syndrome (APS)).
* Active treatment with aspirin, heparin or other anticoagulant therapy, antihypertensives or other drugs used to treat circulation or coagulation disorders .
* Indication for PGT (Preimplantation Genetic Testing).
* Multiple pregnancy.

Where it's running

  • Laura Burunat
    Barcelona, Spain, Spain
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.